Clinical features of Brugada syndrome

Journal of Arrhythmia

Volumn 29, Issue 2, 2013, Pages 65-70

  Shimizu, Wataru ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Brugada syndrome; Diagnosis; Risk stratification; ST segment; Ventricular fibrillation

Indexed keywords

EID: 84882452374     PISSN: 18804276     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joa.2013.01.009     Document Type: Review

References (43)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardio- graphic syndrome: a multicenter report. J Am Coll Cardiol 1992;20: 1391-6.
2. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3. A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97: 457-60. (Pubitemid 28090217)
3. Alings M, Wilde A. Brugada syndrome: clinical data and suggested patho-physiological mechanism. Circulation 1999;99: 666-73. (Pubitemid 29077366)
4. Antzelevitch C, Brugada P, Brugada J, et al. Brugada syndrome. A decade of progress. Circ Res 2002;91: 1114-8.
5. Priori SG, Napolitano C, Gasparini M, et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105: 1342-7. (Pubitemid 34260426)
6. Wilde AA, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106: 2514-9. (Pubitemid 35278811)
7. Brugada J, Brugada R, Antzelevitch C, et al. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105: 73-8. (Pubitemid 34049145)
8. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome. Report of the second consensus conference. Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111: 659-70. (Pubitemid 40216496)
9. Bezzina CR, Shimizu W, Yang P, et al. A common sodium channel promoter haplotype in Asian subjects underlies variability in cardiac conduction. Circulation 2006;113: 338-44. (Pubitemid 43803194)
10. Kanda M, Shimizu W, Matsuo K, et al. Electrophysiologic characteristics and implication of induced ventricular fibrillation in symptomatic patients with Brugada syndrome. J Am Coll Cardiol 2002;39: 1799-805. (Pubitemid 34595291)
11. Eckardt L, Probst V, Smits JP, et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111: 257-63. (Pubitemid 40165330)
12. Di Diego JM, Cordeiro JM, Goodrow RJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation 2002;106: 2004-11. (Pubitemid 35176309)
13. Shimizu W, Matsuo K, Kokubo Y, et al. Sex hormone and gender difference. Role of testosterone on male predominance in Brugada syndrome. J Cardio-vasc Electrophysiol 2007;18: 415-21. (Pubitemid 46435053)
14. Matsuo K, Kurita T, Inagaki M, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999;20: 465-70. (Pubitemid 29116543)
15. Takigawa M, Noda T, Shimizu W, et al. Seasonal and circadian distributions of ventricular fibrillation in patients with Brugada syndrome. Heart Rhythm 2008;5: 1523-7.
16. Mizumaki K, Fujiki A, Tsuneda T, et al. Vagal activity modulates spontaneous augmentation of ST elevation in the daily life of patients with Brugada syndrome. J Cardiovasc Electrophysiol 2004;15: 667-73. (Pubitemid 38757172)
17. Morita H, Kusano-Fukushima K, Nagase S, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002;40: 1437-44. (Pubitemid 35192869)
18. Eckardt L, Kirchhof P, Johna R, et al. Wolff-Parkinson-White syndrome associated with Brugada syndrome. Pacing Clin Electrophysiol 2001;24: 1423-4. (Pubitemid 32881973)
19. Matsuo K, Shimizu W, Kurita T, et al. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998;9: 508-12. (Pubitemid 128721708)
20. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996;27: 1061-70. (Pubitemid 26119611)
21. Atarashi H, Ogawa S, Harumi K, et al. Idiopathic Ventricular Fibrillation Investigators: three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001;37: 1916-20. (Pubitemid 32499980)
22. Smits JP, Eckardt L, Probst V, et al. Genotype-phenotype relationship in Brugada syndrome: electrocardiographic features differentiate SCN5A-related patients from non-SCN5A-related patients. J Am Coll Cardiol 2002;40: 350-6. (Pubitemid 34756299)
23. Priori SG, Wilde A, Horie M, et al. HRS/EHRA/APHRS expert consensus statement on the management of inherited arrhythmias. This document was developed as a partnership between the Heart Rhythm Society (HRS), the European Heart Rhythm Association (EHRA), and Asian Pacific Heart Rhythm Society (APHRS). Heart Rhythm, submitted for publication.
24. Miyamoto K, Yokokawa M, Tanaka K, et al. Diagnostic and prognostic value of type 1 Brugada electrocardiogram at higher (third or second) V1 to V2 recording in men with Brugada syndrome. Am J Cardiol 2007;99: 53-7. (Pubitemid 44969340)
25. Nagase S, Hiramatsu S, Morita H, et al. Electroanatomical correlation of repolarization abnormalities in Brugada syndrome: detection of type 1 electrocardiogram in the right ventricular outflow tract. J Am Coll Cardiol 2010;56: 2143-5.
26. Sarkozy A, Sorgente A, Boussy T, et al. The value of a family history of sudden death in patients with diagnostic type I Brugada ECG pattern. Eur Heart J 2011;32: 2153-60.
27. Shimizu W. Acquired forms of the Brugada syndrome. J Electrocardiol 2005;38: 22-5. (Pubitemid 41436483)
28. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000;11: 1320-9. (Pubitemid 32016854)
29. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000;101: 510-5. (Pubitemid 30080865)
30. Baranchuk A, Nguyen T, Ryu MH, et al. Brugada phenocopy: new terminology and proposed classification. Ann Noninvasive Electrocardiol 2012;17: 299-314.
31. Shimizu W. Acquired form of Brugada syndrome: Chapter 40, . In: Gussak I, Antzelevitch C, Wilde A, Powell B, Ackerman MJ, Shen WK, editors. Electrical diseases of the heart (second edition): genetics, mechanisms, treatment, prevention, Part III. Secondary hereditary and acquired cardiac channelopa-thies, and sudden cardiac death. UK, Springer, in press.
32. Probst V, Veltmann C, Eckardt L, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: results from the FINGER Brugada Syndrome Registry. Circulation 2010;121: 635-43.
33. Kamakura S, Ohe T, Nakazawa K, et al. Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. Circ Arrhythm Electrophysiol 2009;2: 495-503.
34. Amin AS, de Groot EA, Ruijter JM, et al. Exercise-induced ECG changes in Brugada 1328 syndrome. Circ Arrhythm Electrophysiol 2009;2: 531-9.
35. Makimoto H, Nakagawa E, Takaki H, et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010;56: 1576-84.
36. Ikeda T, Sakurada H, Sakabe K, et al. Assessment of noninvasive markers in identifying patients at risk in the Brugada syndrome: insight into risk stratification. J Am Coll Cardiol 2001;37: 16-34.
37. Morita H, Kusano KF, Miura D, et al. Fragmented QRS as a marker of conduction abnormality and a predictor of prognosis of Brugada syndrome. Circulation 2008;118: 1697-704.
38. Priori SG, Gasparini M, Napolitano C, et al. Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. J Am Coll Cardiol 2012;59: 37-45.
39. Morita H, Kusano KF, Nagase S, et al. Atrial fibrillation and atrial vulnerability in patients with Brugada syndrome. J Am Coll Cardiol 2002;40: 1437-44. (Pubitemid 35192869)
40. Kusano KF, Taniyama M, Nakamura K, et al. Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgrounds. J Am Coll Cardiol 2008;51: 1169-75. (Pubitemid 351382097)
41. Makimoto H, Kamakura S, Aihara N, et al. Clinical impact of the number of extrastimuli in programmed electrical stimulation in patients with Brugada type 1 electrocardiogram. Heart Rhythm 2012;9: 242-8.
42. Márquez MF, Rivera J, Hermosillo AG, et al. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope. Pacing Clin Electrophysiol 2005;28: 870-3. (Pubitemid 41648232)
43. Yokokawa M, Okamura H, Noda T, et al. Neurally-mediated syncope as a cause of syncope in patients with Brugada electrocardiogram. J Cardiovasc Electrophysiol 2010;21: 186-92.